Updates in Multiple Myeloma in 2025: From Bench to Bedside
Constantine S. Mitsiades, MD, PhD, shares an update on the ongoing advances in multiple myeloma research, emphasizing his lab’s work in overcoming treatment resistance.
Multiple Myeloma Patient Symposium Video Presentations
The Latest From Experts
The 2026 Multiple Myeloma Patient Education Symposium will be held on Saturday, April 11, 2026, at 9 a.m. ET. In-person and virtual registration options available.
This all-day program features in-person presentations and a Q&A session with our experts from the Jerome Lipper Multiple Myeloma Center, as well as a live virtual option.
The in-person event will be held at the Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115. Free parking is available at the Martin Center after 8 a.m.
Virtual attendees can join the live presentations via Zoom (Passcode: 488568)
To register, please email MM_DFCI2@dfci.harvard.edu and specify if you will attend in person or virtually.
Highlights From the 2025 Multiple Myeloma Patient Symposium
View the complete playlist for the 2025 Multiple Myeloma Patient Education Symposium
Individual videos:
- Multiple Myeloma: A Patient’s Perspective, presented by Debbie Graff
- Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk, presented by Jacob Laubach, MD, MPP, and Constantine S. Mitsiades, MD, PhD
- Updates in Multiple Myeloma in 2025: From Bench to Bedside, presented by Constantine S. Mitsiades, MD, PhD
- 2025 Updates in the Management of SMM/MGUS and the Prevention of Progression, presented by Yuxin Liu, MD
- Therapeutic Advances in Newly Diagnosed Multiple Myeloma (and Their Implications), presented by Clifton Mo, MD
- Updates on AL Amyloidosis Treatment: What's New in 2025, presented by Giada Bianchi, MD
- CAR T and Bispecific Antibody Therapies in Multiple Myeloma, presented by Shonali Midha, MD
- Future of Novel Therapies in the Management of Relapsed and Refractory Multiple Myeloma, presented by Paul Richardson, MD
Support for the 2025 Multiple Myeloma Patient Symposium was generously provided by the R.J. Corman Multiple Myeloma Research Fund.
Highlights From the 2024 Multiple Myeloma Patient Symposium
View the complete playlist for the 2024 Multiple Myeloma Patient Education Symposium
Individual videos:
- Updates in Multiple Myeloma in 2024: From Bench to Bedside, presented by Kenneth Anderson, MD
- Multiple Myeloma 101: Diagnosis, Prognosis, and Risk, presented by Paul Richardson, MD, on behalf of Nikhil Munshi, MD
- CAR T Cells in Multiple Myeloma, presented by Adam Sperling, MD, PhD
- Updates on AL Amyloidosis Treatment: What's New in 2024, presented by Giada Bianchi, MD
- Updates in the Management of SMM/MGUS and the Prevention of Progression, presented by Yuxin Liu, MD
- Continued Evolution of Therapy for Patients with Newly Diagnosed Multiple Myeloma, presented by Clifton Mo, MD
- Bispecific Antibody Therapy in Multiple Myeloma, presented by Shonali Midha, MD
- Future of Novel and Next Generation Therapy in the Management of Relapsed/Refractory Multiple Myeloma, presented by Paul Richardson, MD
New Patient Appointments
For adults: 877-442-3324
For children: 888-733-4662
Expert Care and Treatment for Multiple Myeloma
The Multiple Myeloma Program within the Hematologic Oncology Treatment Center includes physicians, clinicians, and research scientists who work together on promising new therapies.
Your care team will collaborate to develop a comprehensive, personalized treatment plan that offers the most advanced therapies and an array of supportive resources.